Citation Impact
Citing Papers
p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death
2005 Standout
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Exercise training increases size of hippocampus and improves memory
2011 Standout
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells
2020 StandoutNobel
Behavioral phenotypes of amyloid‐based genetically modified mouse models of Alzheimer's disease
2005
Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice
2004
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
2016 StandoutNature
ω-6 Polyunsaturated fatty acids extend life span through the activation of autophagy
2013 StandoutNobel
Intracranial administration of deglycosylated C-terminal-specific anti-Aβ antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice
2006
The immune system, amyloid‐β peptide, and Alzheimer's disease
2005
Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice
2003
Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer’s Disease
2014
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy
2005
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
2002 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Advances in the development of biomarkers for Alzheimer’s disease: from CSF total tau and Aβ1–42 proteins to phosphorylated tau protein
2003
Neuronal cells show regulatory differences in the hsp70 gene response
2002
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Cellular senescence: when bad things happen to good cells
2007 Standout
Longitudinal Change of Biomarkers in Cognitive Decline
2011
Polysialic acid in the plasticity of the developing and adult vertebrate nervous system
2007
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
2006
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Cerebrospinal fluid protein biomarkers for Alzheimer’s disease
2004
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
Decreased cerebrospinal fluid Aβ 42 correlates with brain atrophy in cognitively normal elderly
2009
Alzheimer's disease
2011 Standout
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
2011
Mild Cognitive Impairment
2011 Standout
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
2014
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
2010
Conditional Forebrain Inactivation of Nicastrin Causes Progressive Memory Impairment and Age-Related Neurodegeneration
2009 StandoutNobel
CSF markers for incipient Alzheimer's disease
2003
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
2002 StandoutScience
CSF Biomarkers
2009
Decreased β-Amyloid1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease
2003
The specific role of histone deacetylase 2 in adult neurogenesis
2010
Longitudinal stability of CSF tau levels in Alzheimer patients
1999
Anomalously phosphorylated tau and Aβ fragments in the CSF correlates with cognitive impairment in MCI subjects
2005
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Biological roles of glycans
2016 Standout
CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival
2006
Geldanamycin activates Hsp70 response and attenuates okadaic acid-induced cytotoxicity in human retinal pigment epithelial cells
2005
Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer’s disease
2002
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Shedding light on the cell biology of extracellular vesicles
2018 Standout
The immunoglobulin superfamily of neuronal cell adhesion molecules: Lessons from animal models and correlation with human disease
2008
Cerebrospinal Fluid Tau and β-Amyloid
2003
Geldanamycin increases 4-hydroxynonenal (HNE)-induced cell death in human retinal pigment epithelial cells
2005
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
2009 Standout
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
2010
APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
2009
Stress and the brain: from adaptation to disease
2005 Standout
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
2013 Standout
Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease
2009
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Alzheimer's disease
2006 Standout
Alzheimer's disease
2016 Standout
Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
2011 Standout
Synaptic Strength as a Function of Post- versus Presynaptic Expression of the Neural Cell Adhesion Molecule NCAM
2000
Biomarker Modeling of Alzheimer’s Disease
2013
Extracellular vesicles – Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases
2015
The Role of Apolipoprotein E in Alzheimer's Disease
2009
Alzheimer's Disease
2010 Standout
Direct binding of polysialic acid to a brain-derived neurotrophic factor depends on the degree of polymerization
2008
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Ubiquitin-Binding Protein p62 Expression Is Induced during Apoptosis and Proteasomal Inhibition in Neuronal Cells
2001
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
2012
Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice
2007
Amyloid biomarkers in Alzheimer's disease
2015
Activity-Dependent Validation of Excitatory versus Inhibitory Synapses by Neuroligin-1 versus Neuroligin-2
2007 StandoutNobel
Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
2009
The epigenetics of aging and neurodegeneration
2015
Evidence for Ordering of Alzheimer Disease Biomarkers
2011
Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosisof Alzheimer Disease
2004
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
2009
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort
2010
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
2007
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
2009 Nature
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease
2008
Stress, cognitive impairment and cell adhesion molecules
2004
Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
2009
MDGAs interact selectively with neuroligin-2 but not other neuroligins to regulate inhibitory synapse development
2012 StandoutNobel
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
2012
Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease
2013
2016
MRI and CSF biomarkers in normal, MCI, and AD subjects
2009
Change of the Death Pathway in Senescent Human Fibroblasts in Response to DNA Damage Is Caused by an Inability To Stabilize p53
2001
Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
2013
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
2011
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
2014
A Century of Alzheimer's Disease
2006 StandoutScience
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI
2007
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
2007
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
2000
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
Longitudinal changes of CSF biomarkers in memory clinic patients
2007
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
A water-soluble metal–organic complex array as a multinuclear heterometallic peptide amphiphile that shows unconventional anion dependency in its self-assembly
2015 StandoutNobel
The role of extracellular vesicles in neurodegenerative diseases
2016
Dementia with Lewy bodies.
2004
Ischemic Cell Death in Brain Neurons
1999 Standout
Multiple neurotrophic signals converge in surviving CA1 neurons of the gerbil hippocampus following transient forebrain ischemia
1998
Plasma tau in Alzheimer disease
2016 StandoutNobel
A Candidate Plasma Protein Classifier to Identify Alzheimer's Disease
2014
Selective Estrogen Receptor Modulators Differentially Regulate Alzheimer-Like Changes in Female 3xTg-AD Mice
2008
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
2007 StandoutScience
Polysialic acid governs T-cell development by regulating progenitor access to the thymus
2009 StandoutNobel
Ultrasensitive and Highly Selective Detection of Alzheimer’s Disease Biomarker Using Two-Photon Rayleigh Scattering Properties of Gold Nanoparticle
2009
Works of Tero Tapiola being referenced
Differentiation of Geriatric Major Depression From Alzheimer’s Disease With CSF Tau Protein Phosphorylated at Threonine 231
2003
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
2009
Expression of Transcriptional Repressor Protein mSin3A But Not mSin3B Is Induced during Neuronal Apoptosis
1998
Down-Regulation of Ku Autoantigen, DNA-Dependent Protein Kinase, and Poly(ADP-ribose) Polymerase during Cellular Senescence
1997
The Calretinin‐containing Mossy Cells Survive Excitotoxic Insult in the Gerbil Dentate Gyrus. Comparison of Excitotoxicity‐induced Neuropathological Changes in the Gerbil and Rat
1996
Neuronal apoptosis induced by histone deacetylase inhibitors
1998
Fimbria–Fornix Lesion Does Not Affect APP Levels and Amyloid Deposition in the Hippocampus of APP+PS1 Double Transgenic Mice
2002
Remodeling of neuronal circuitries in human temporal lobe epilepsy: Increased expression of highly polysialylated neural cell adhesion molecule in the hippocampus and the entorhinal cortex
1998
Genetic study evaluating LDLR polymorphisms and Alzheimer's disease
2007
Aβ levels in serum, CSF and brain, and cognitive deficits in APP + PS1 transgenic mice
2003
Hippocampal plasticity in Alzheimer's disease: changes in highly polysialylated NCAM immunoreactivity in the hippocampal formation
1999
Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28k immunoreactivity in the entorhinal cortex in Alzheimer's disease
1999
Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's disease
2000
Distinct mode of apoptosis induced by genotoxic agent etoposide and serum withdrawal in neuroblastoma cells
1998
Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation
2004
Hippocampal Aβ42 Levels Correlate with Spatial Memory Deficit in APP and PS1 Double Transgenic Mice
2002
Differential Diagnosis of Alzheimer Disease With Cerebrospinal Fluid Levels of Tau Protein Phosphorylated at Threonine 231
2002
The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimerʼs disease
1997
The Effects of Long-Term Treatment with Metrifonate, a Cholinesterase Inhibitor, on Cholinergic Activity, Amyloid Pathology, and Cognitive Function in APP and PS1 Doubly Transgenic Mice
2002
Distinct mechanisms underlay DNA disintegration during apoptosis induced by genotoxic and nongenotoxic agents in neuroblastoma cells
1999
CSF tau and Aβ42 levels in patients with Down’s syndrome
2001
Relationship between apoE genotype and CSF β-amyloid (1â42) and tau in patients with probable and definite Alzheimer's disease
2000
CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease
1998